Name: microRNA Purification Kit
Brand: Norgen Biotek Corp.
SKU: 21300
Price: 249.000000 USD
Availability: InStock

Features and Benefits

Isolate and extract high quality & quantity miRNA in 30 minutes
Two column kit- eliminate large RNA on the first column and capture microRNA on a second column
Elute microRNA in 25 µL ready for miRNA profiling
Process a wide range of samples- cell, tissue, bacteria, bodily fluids, etc.
Purification is based on spin column chromatography that uses Norgen’s proprietary resin separation matrix

This kit provides a rapid method for the isolation and purification of small RNA molecules (< 200 nt) from cultured animal cells, small tissue samples, bacterial cells, plants, and blood.

Two columns are provided with this kit. The first column captures large RNA, while the small RNA are captured on a second column and are eluted concentrated in 25 µL of nuclease-free water.

The small RNA can be used in various downstream applications relating to miRNA profiling, gene regulation, and functional analysis. The eluted RNA is ready for RT-qPCR, microarrays, and NGS applications.

Background

These small RNAs include regulatory RNA molecules such as microRNA (miRNA) and short interfering RNA (siRNA), as well as tRNA and 5S rRNA. Small RNA molecules are often studied due to their ability to regulate gene expression. miRNAs and siRNAs are typically 20-25 nucleotides long and regulate gene expression by binding to mRNA molecules and affecting their stability or translation.

Details

Supporting Data

Figure 1. High Quality of Isolated RNA with Better Size Exclusion. Small RNA was isolated from HeLa cells using Norgen's microRNA Purification Kit (Lanes C and D) and a competitor's kit (Lanes A and B). Ten microliters of the 50 µL purified small RNA were run on an 8% urea-agarose gel. Lane M is Norgen's 100b RNA ladder. Note that Norgen's kit is isolating only the small (<200 nt) RNA species, with no contaminating larger RNA.

Figure 2. Efficient Removal of Large RNA Species. Different RNA species were isolated from 10⁶ HeLa cells, resolved on an Agilent® Lab-On-A-Chip, and electropherograms were generated. Panel A contains all the RNA species present in 10⁶ HeLa cells as isolated with Norgen's Total RNA Purification Kit and acts as a control. Panel B and C contain RNA that was isolated from 10⁶ HeLa cells using Norgen’s microRNA Purification Kit. One microliter of the 50 µL purified RNA for each fraction was loaded. Panel B shows the large RNA species removed using the Large RNA Removal Columns, and no small RNA can be detected. Panel C shows the small RNA that is isolated using the microRNA Enrichment Columns and shows that there is no contamination of the small RNA with any large RNA species above 200 nt. This demonstrates the effective separation of the small RNA from the large RNA species using Norgen's microRNA Purification Kit.

Figure 3. Effective Small RNA Amplification by End-Point RT-PCR. Norgen's microRNA Purification Kit isolates small RNA that could be amplified in RT-PCR using the poly (A) polymerase extension method. Small RNA was isolated from 1 million HeLa cells, and 10 µL of the 20 µL isolated small RNA were polyadenylated in a 50 µL Poly-(A)-Polymerase reaction. Seven microliters of the polyadenylated RNA were used in a 20 µL reverse transcription reaction with a poly T adaptor primer. One microliter of the reverse transcription was used in a 20 µL PCR reaction with primers against the human microRNAs (miR-21) and 5S rRNA. Panel A shows the amplification of the miR-21 transcript from small RNAs while Panel B shows the 5S rRNA amplification from small RNAs. Lane 1 in both panels shows the results when total RNA isolated from 1 million HeLa cells using Norgen's Total RNA Purification Kit was used as a control. Lanes 2 and 3 contain the successful RT-PCR when the microRNA isolated using Norgen's microRNA Purification Kit was used as the template, and Lanes 4 contain the non-template control. The RT-PCR was successful for both reactions using the microRNA as the template. All PCR products were resolved on a 1X TAE, 3% agarose gel using Norgen's PCR Ranger as the molecular weight ladder.

Figure 4. Better Recovery of miRNAs by Norgen's microRNA Purification Kit. Norgen's microRNA Purification Kit recovers microRNA more effectively than its competitors. Small RNA was isolated from 0.75 million HeLa cells using Norgen's microRNA Purification Kit and a competitors' kits. Relative expression of (A) miR-21, (B) miR-19, and (C) 5S rRNA was determined by RT-qPCR of polyadenylated total RNA samples. RT-qPCR was performed according to Shi and Chiang (2005). Fifteen microliters of the 50 µL isolated RNA were polyadenylated in a 50 µL Poly-(A)-Polymerase reaction. Four microliters of the polyadenylated RNA were used in a 20 µL reverse transcription reaction with a poly T adaptor primer. One microliter of the reverse transcription was then used in a 20 µL qPCR reaction with primers against the human microRNAs (miR-19 and miR-21) and house-keeping small RNA (5S rRNA). The resulting threshold cycle (Ct) values were summarized in the graph. Blue = Norgen's microRNA Purification Kit; orange = Silica-based Competitor micro-RNA Kit; green = Silica-based Competitor Total RNA Kit; red = Phenol-based reagent protocol; yellow = No Template Control. Norgen's microRNA Purification Kit recovered more miRNAs (lower Ct) than the competitor's microRNA-specific Kit.

Kit Specifications
Maximum Column Binding Capacity	Up to 50 μg RNA
Maximum Column Loading Volume	650 μL
Minimum Elution Volume	20 μL
Size of RNA Purified	All sizes, including small RNA < 200 nt
Time to Complete 10 Purifications	25 minutes
Maximum Amount of Starting Material: Animal Cells Animal Tissues Bacteria Plant Tissues Blood	3 x 10⁶ cells 5-25 mg 1 x 10⁹ cells 50 mg 100 μL

Storage Conditions and Product Stability
All solutions should be kept tightly sealed and stored at room temperature. This kit is stable for 1 year after the date of shipment.

Component	Cat. 21300 (25 preps)
Buffer RL	40 mL
Wash Solution A	38 mL
Elution Solution A	6 mL
Large RNA Removal Column	25
microRNA Enrichment Column	25
Collection Tube	50
Elution Tubes (1.7 mL)	50
Product Insert	1

Documentation

FLYERS

Flyer

RELATED BLOGS

FAQs

Why do I have poor RNA recovery?

Poor RNA recovery could be due to one or more of the following:

Incomplete lysis of cells or tissue. Ensure that the appropriate amount of Buffer RL was used for the amount of cells or tissue.
Large RNA Removal Column has become clogged. Do not exceed the recommended amounts of starting materials. The amount of starting material may need to be decreased if the column shows clogging below the recommended levels. See FAQ related to “Clogged Column” below.
An alternative elution solution was used. It is recommended that the Elution Solution A supplied with this kit be used for maximum RNA recovery.
Low RNA content. Different tissues and cells have different RNA contents. Some tissues may not contain small RNA at detectable levels when processing the small sample sizes required for this procedure.
Flowthrough from the first binding step was discarded. The flowthrough from the binding step with the Large RNA Removal Column contains the small RNA molecules, thus ensure that it is not inadvertently discarded.
Ethanol was not added to the flowthrough before binding to the microRNA Enrichment Column. Ensure that the appropriate amount of ethanol was added to the flowthrough from the first binding step before it is applied to the microRNA Enrichment Column. This is imperative in order to capture the small RNA molecules.
Ethanol was not added to the Wash Solution A. Ensure that 90 mL of 96 – 100% ethanol is added to the supplied Wash Solution A prior to use.
Cell Culture: Cell monolayer was not washed with PBS. Ensure that the cell monolayer is washed with the appropriate amount of PBS in order to remove residual media from cells.
Bacteria: All traces of media not removed. Ensure that all media is removed prior to the addition of the Buffer RL through aspiration.

I noticed the columns are clogged. What causes this?

Column clogging can result from one or a combination of the following factors:

Insufficient solubilization of cells or tissues. Ensure that the appropriate amount of Lysis Buffer was used for the amount of cells or tissue.
Maximum number of cells or amount of tissue exceeds kit specifications. Refer to specifications to determine if the amount of starting material falls within kit specifications.
High amounts of genomic DNA present in sample. The lysate may be passed through a 25 gauge needle attached to a syringe 5-10 times in order to shear the genomic DNA prior to loading onto the Large RNA Removal Column.
Centrifuge temperature is too low. Ensure that the centrifuge remains at room temperature throughout the procedure. Temperatures below 15°C may cause precipitates to form that can cause the columns to clog.

Why is the RNA degraded?

RNA can be degraded due to the following factors:

RNase contamination. RNases may be introduced during the use of the kit. Ensure proper procedures are followed when working with RNA. Please refer to “Working with RNA” at the beginning of this user guide.
Procedure not performed quickly enough. In order to maintain the integrity of the RNA, it is important that the procedure be performed quickly. This is especially important for the Cell Lysate Preparation Step in the Animal Tissue protocol, since the RNA in animal tissues is not protected after harvesting until it is disrupted and homogenized.
Improper storage of the purified RNA. For short term storage, RNA samples may be stored at –20°C for a few days. It is recommended that samples be stored at –70°C for longer term storage.
Frozen tissues or pellets were allowed to thaw prior to disruption. Tissue samples should be flash-frozen in liquid nitrogen and transferred immediately to a -70°C freezer for long term storage. Do not allow frozen tissues to thaw prior to grinding with the mortar and pestle in order to ensure that the integrity of the RNA is not compromised.

Why is the RNA not performing well in downstream applications?

If the RNA does not perform well in downstream applications, it may be due to one or more of the following:

RNA was not washed 3 times with the provided Wash Solution A. Traces of salt from the binding step may remain in the sample if the well is not washed 3 times with Wash Solution A. Salt may interfere with downstream applications, and thus must be washed from the well.
Ethanol carryover. Ensure that the dry spin under Column Wash in the centrifugation protocol or the extended vacuum in the vacuum protocol is performed in order to remove traces of ethanol prior to elution. Ethanol is known to interfere with many downstream applications.

I noticed genomic DNA contamination. How to prevent/correct this?

The contamination with genomic DNA may be due to large amount of starting material used. Perform RNase-free DNase I digestion on the RNA sample after elution to remove genomic DNA contamination. It is recommended that Norgen’s RNase-Free DNase I Kit (Product # 25710) be used for this step.

Why is there large RNA species present in the elution?

Large RNA species may be present in the elution due to:

Improper amount of ethanol added to the lysate before binding to the Large RNA Removal Column. Ensure that the appropriate amount of ethanol was added to the lysate before it is applied to the Large RNA Removal Column. This is imperative in order to capture the large RNA molecules onto the column.
Large amount of starting material used. Repeat purification using less starting material. Alternatively, the isolation procedure can be repeated using the elution as the input. The elution volume should first be adjusted to 300 µL using the provided Buffer RL. The procedure can then be followed as written in the manual, starting with the addition of ethanol, centrifuging the lysate in order to pellet any debris, and applying the clarified lysate to the Large RNA Removal Column. Repeating the procedure should result in the removal of the large, contaminating RNA species.

Is it possible to purify microRNA from frozen blood samples?

Although it is recommended to use fresh non-coagulating (EDTA) blood for RNA purification, frozen blood samples can also be processed. Please thaw the frozen blood samples on ice for 15 minutes, and then at room temperature (21 degrees) for 10 minutes before proceeding to the kit protocol. Please note that frozen blood samples are known to yield more degraded RNA compared to fresh blood samples.

Citations

Title	Nutritional supplementation of an apple callus extract to target epidermal aging
Citation	Journal of Food, Nutrition and Diet Science 2024.
Authors	Julia Baumann1 , Franziska Wandrey1 , Kathrin Nowak1 , Torsten Grothe

Title	Discrimination of extracellular miRNA sources for the identification of tumor-related functions based on nanowire thermofluidics
Citation	Device 2024.
Authors	Kunanon Chattrairat Akira Yokoi Min Zhang Mikiko Iida Kosuke Yoshida Masami Kitagawa Ayuka Niwa Masatoshi Maeki Takeshi Hasegawa Takeshi Yokoyama Yoshikazu Tanaka Yusuke Miyazaki Wataru Shinoda Manabu Tokeshi Kazuki Nagashima Takeshi Yanagida Hiroaki Kajiyama Yoshinobu Baba Takao Yasui 18

Title	Nrf2 Plays a Key Role in Erythropoiesis during Aging
Citation	Antioxidants 2024.
Authors	Serge Cedrick Toya Mbiandjeu 1,Angela Siciliano 2,3,Alessandro Mattè 1,Enrica Federti 2,3,Massimiliano Perduca 4ORCID,Davide Melisi 1ORCID,Immacolata Andolfo 5,6,Angela Amoresano 7,Achille Iolascon 5,6ORCID,Maria Teresa Valenti 8ORCID,Francesco Turrini 9,Michele Bovi 4,Arianna Pisani 4,Antonio Recchiuti 10ORCID,Domenico Mattoscio 10ORCID,Veronica Riccardi 2,Luca Dalle Carbonare 2,3ORCID,Carlo Brugnara 11,12,Narla Mohandas 13 andLucia De Franceschi 2,3,*

Title	Mir-155-5p targets TP53INP1 to promote proliferative phenotype in hypersensitivity pneumonitis lung fibroblasts
Citation	Non-coding RNA Research 2024.
Authors	Marco Espina-Ordoñez a b, Yalbi Itzel Balderas-Martínez c, Ana Lilia Torres-Machorro d, Iliana Herrera a, Mariel Maldonado a, Yair Romero e, Fernanda Toscano-Marquez a, Annie Pardo e, Moisés Selman a, José Cisneros

Title	Characterization of microRNAs in the cyst nematode Heterodera glycines identifies possible candidates involved in cross-kingdom interactions with its host Glycine max
Citation	RNA Biology 2023.
Authors	Dave T. Ste-Croix, Richard R. Bélanger & Benjamin Mimee

Title	Expression of miRNA-140 in Chondrocytes and Synovial Fluid of Knee Joints in Patients with Osteoarthritis
Citation	Chinese Medical Sciences Journal 2017.
Authors	H Si, Y Zeng, Z Zhou, F Pei, Y Lu, J Cheng, B Shen

Title	Intra-articular injection of microRNA-140 (miRNA-140) alleviates osteoarthritis (OA) progression by modulating extracellular matrix (ECM) homeostasis in rats
Citation	Osteoarthritis and Cartilage 2017.
Authors	Si, H. B., Zeng, Y., Liu, S. Y., Zhou, Z. K., Chen, Y. N., Cheng, J. Q., ... & Shen, B. (2017)

Title	Genomewide Association Study of African Children Identifies Association of SCHIP1 and PDE8A with Facial Size and Shape
Citation	PLoS One 2016.
Authors	Cole, J. B., Manyama, M., Kimwaga, E., Mathayo, J., Larson, J. R., Liberton, D. K., ... & Mio, W

Title	Circulating microRNA Profiling Needs Further Refinement Before Clinical Use in Patients With Aortic Stenosis
Citation	Journal of the American Heart Association 2015.
Authors	S Coffey, MJA Williams, V Phillips, GT Jones

Title	Human microRNAs profiling in response to influenza A viruses (subtypes pH1N1, H3N2, and H5N1)
Citation	Experimental Biology and Medicine 2015.
Authors	Makkoch, J., Poomipak, W., Saengchoowong, S., Khongnomnan, K., Praianantathavorn, K., Jinato, T., ... & Payungporn, S

microRNA Purification Kit